Page 174 - medicina-integrativa_compress

CAPÍTULO 15 NEUROPATÍA PERIFÉRICA 167

53. Ziegler D, Nowak H, Kempler P, et al: Treatment of symptomatic 76. Goldstein DJ, Lu Y, Detke MJ, et al: Duloxetine vs. placebo in
diabetic polyneuropathy with the antioxidant alpha-lipoic acid: patients with painful diabetic neuropathy. Pain 116:109-118, 2005.
A meta-analysis. Diabet Med 21:114-121, 2004. 77. Michael CR, Veeraindar G, Nadia RK, et al: Venalafaxine extended
54. Hahm JR, Kim BJ, Kim KW: Clinical experience with thioctacid release in the treatment of painful diabetic neuropathy: A double-
(thioctic acid) in the treatment of distal symmetric polyneuropathy blind, placebo-controlled study. Pain 110:697-706, 2004.
in Korean diabetic patients. J Diabetes Complications 18:79-85, 78. Sindrup SH, Bach FW, Madsen C, et al: Venalafaxine versus
2004. imipramine in painful polyneuropathy: A randomized, controlled
55. Tankova S, Cherninkova DK: Treatment for diabetic trial. Neurology 60:1284-1289, 2003.
mononeuropathy with alpha-lipoic acid. Int J Clin Pract 59: 79. Tasmuth T, Hartel B, Kalso E: Venalafaxine in neuropathic pain
645-650, 2005. following treatment of breast cancer. Eur J Pain 6:17-24, 2002.
56. Smith AR, Shenvi SV, Widlansky M, et al: Lipoic acid as a potential 80. Morello CM, Leckband SG, Stoner CP, et al: Randomized double-
therapy for chronic diseases associated with oxidative stress. Curr blind study comparing the efficacy of gabapentin with amitriptyline
Med Chem 11:1135-1146, 2004. on diabetic peripheral neuropathy pain. Arch Intern Med 159:1931-
57. Schreeb KH, Freudenthaler S, Vormfelde SV, et al: Comparative 1937, 1999.
bioavailability of two vitamin B 1 preparations: Benfotiamine and 81. Backonja M, Beydon A, Edwards KR, et al: Gabapentin for the
thiamine mononitrate. Eur J Clin Pharmacol 52:319-320, 1997. symptomatic treatment of painful neuropathy in patients with
58. Haupt E, Ledermann H, Kopcke W: Benfothiamine in treatment of diabetes mellitus: A randomized controlled trial. JAMA 280:
diabetic polyneuropathy. Paper presented at the 4th International 1831-1836, 1998.
Symposium on Diabetic Neuropathy, July 15-19, 1997. 82. Adriaensen H, Plaghki L, Mathieu C, et al: Critical review of oral
59. Barkai L, Kempler P, Kadar E, Feher A: Benfothiamine treatment for drug treatments for diabetic neuropathic pain—clinical outcomes
peripheral sensory nerve dysfunction in diabetic adolescents. Paper based on efficacy and safety data from placebo-controlled and direct
presented at the 4th International Symposium on Diabetic comparative studies. Diabetes Metab Res Rev 21:231-240, 2005.
Neuropathy, July 15-19, 1997. 83. Backonja MM: Anticonvulsants (antineuropathics) for neuropathic
60. Sadekov RA, Danilov AB, Vein AM: Diabetic polyneuropathy pain syndromes. Clin J Pain 16:S67-S72, 2000.
treatment by milgamma-100 preparation. (Article in Russian.) 84. Chen H, Lamer T, Rho R, et al: Contemporary management of
Zh Nevrol Psikhiatr Im S S Korsakova 98:30-32, 1998. neuropathic pain for the primary care physician. Mayo Clin Proc
61. Simeonov S, Pavlova M, Mitkov M, et al: Therapeutic efficacy of 79:1533-1545, 2004.
“milgamma” in patients with painful diabetic neuropathy. Folia Med 85. Gee NS, Brown JP, Dissanayake VU, et al: The novel anticonvulsant
(Plovdiv) 39:5-10, 1997. drug, gabapentin (Neurontin), binds to the α 2 -δ subunit of a
62. Stracke H, Lindemann A, Federlin K: A benfotiamine-vitamin B calcium channel. J Biol Chem 271:5768-5776, 1996.
combination in treatment of diabetic polyneuropathy. Exp Clin 86. Luo ZD, Chaplan SR, Higuera ES, et al: Upregulation of dorsal root
Endocrinol Diabetes 104:311-316, 1996. ganglion α 2 -δ calcium channel subunit and its correlation with
63. Haupt E, Ledermann H, Kopcke W: Benfotiamine in the allodynia in spinal nerve-injured rats. J Neurosci 21:1868-1875, 2001.
treatment of diabetic polyneuropathy: A three-week randomized, 87. Gao BS, Sekido Y, Maximov A, et al: Functional properties of a new
controlled pilot study (BEDIP Study). Int J Clin Pharmacol Ther voltage-dependent calcium channel alpha 2 -delta auxiliary subunit
43:304, 2005. gene (CACNA2D2). J Biol Chem 275:12237-12242, 2000.
64. Babaci-Jadidi R, Karachalias N, Ahmed S, et al: Prevention of 88. Richter RW, Portenoy R, Sharma U, et al: Relief of painful
incipient diabetic nephropathy by high-dose thiamine and diabetic peripheral neuropathy with pregabalin: A randomized,
benfotiamine. Diabetes 52:2110-2120, 2003. placebo-controlled trial. J Pain 6:253-260, 2005.
65. Hammes HP, Du X, Edelstein D, et al: Benfotiamine blocks three 89. Frampton JE, Foster RH: Pregabalin: In the treatment of
major pathways of hyperglycemic damage and prevents postherpetic neuralgia. Drugs 65:111-118, 2005.
experimental diabetic retinopathy. Nat Med 9:294-299, 2003. 90. Waldman SD: Diabetic neuropathy: Diagnosis and treatment for the
66. Tutuncu NB, Bayractar M, Varli K: Reversal of defective nerve pain management specialist. Curr Rev Pain 4:383-387, 2000.
conduction with vitamin E supplementation in type 2 diabetes: 91. Randinitis EJ, Posvar EL, Alvey CW, et al: Pharmacokinetics of
A preliminary study. Diabetes Care 21:1915-1918, 1998. pregabalin in subjects with various degrees of renal function. J Clin
67. Robbins WR: Clinical applications of capsaicinoids. Clin J Pain Pharmacol 43:277-283, 2003.
16(2 Suppl):S86-S89, 2000. 92. Kumar D, Marshall H: Diabetic peripheral neuropathy:
68. Markovits E, Gilhar A: Capsaicin: An effective treatment in pain. Int Amelioration of pain with transcutaneous electrostimulation.
J Dermatol 36:401-404, 1997. Diabetes Care 20:1702-1705, 1997.
69. Zhang WY, Po LW; The effectiveness of topically applied capsaicin: 93. Tesfaye S, Watt J, Benbow SJ, et al: Electrical spinal-cord stimulation
A meta-analysis. Eur J Clin Pharmacol 46:517-522, 1994. for painful diabetic peripheral neuropathy. Lancet 348:1696-1701,
70. Joss JD: Tricyclic antidepressant use in diabetic neuropathy. Ann 1996.
© Elsevier. Es una publicación MASSON. Fotocopiar sin autorización es un delito.
Pharmacol 33:996-1000, 1999. 94. Hamza M, White PF, Craig WF, et al: Percutaneous electrical nerve
71. Ross E: The evolving role of antiepileptic drugs in treating stimulation: A novel analgesic therapy for diabetic neuropathic pain.
neuropathic pain. Neurology 55(5 Suppl 1):S41-S46, 2000. Diabetes Care 23:365-370, 2000.
72. Sindrup SH, Jensen TS: Pharmacologic treatment of pain in 95. Abram S: Neural blockade for neuropathic pain. Clin J Pain 16:
polyneuropathy. Neurology 55:915-920, 2000. S56-S61, 2000.
73. Max MB, Lynch SA, Muir J, et al: Effects of desipramine, 96. Nishizawa M, Sutherland WH, Nukada H: Gosha-jinki-gan (herbal
amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl medicine) in streptozocin-induced diabetic neuropathy. J Neurol Sci
J Med 326:1250-1256, 1992. 132:177-181, 1995.
74. Sindrup SH, Gram LF, Brosen K, et al: The selective serotonin 97. Mingrui L, Xiang W: Clinical observation on treatment of diabetic
reuptake inhibitor paroextine is effective in the treatment of diabetic peripheral neuropathy with reinforced tianma duzhong capsule.
neuropathy symptoms. Pain 42:135-144, 1990. J Tradit Chin Med 19:182-184, 1999.
75. Waldman SD: Diabetic neuropathy: Diagnosis and treatment for the 98. Farong Z: Advances in treatment of diabetic neuropathy by
pain management specialist. Curr Rev Pain 4:383-387, 2000. traditional Chinese medicine. J Tradit Chin Med 18:146-152, 1998.